2-Mercaptobenzimidazole (2-MBI) is a member of the thioureylene compound family known for their potent antithyroid activity. Male Fischer-344 rats were exposed to 0.0, 3.13, 12.5, and 50.0 mg/m3 of 2-MBI via inhalation for 13 wk. Follicular cell hyperplasia occurred in the thyroid glands of rats from the 3 2-MBI treatment groups. Thyrotrophs in the pituitary glands from rats in these 3 groups were hyperplastic, and they had varying numbers of hypertrophic cells with either eosinophilic stippled cytoplasm or with eosinophilic globules within 1 or more large vacuoles that displaced the nucleus. These cells were compared by immunohistochemistry and ultrastructural examination to "thyroidectomy cells" within the anterior pituitary glands of thyroparathyroidectomized rats and were determined to be identical to them. Immunohistochemical staining for the &beta;-chain of thyroid-stimulating hormone confirmed that the hyperplastic and hypertrophic cells were thyrotrophs. Ultrastructurally, hypertrophic cells in 2-MBI-treated rats and thyroidectomy cells in thyroparathyroidectomized rats had expanded cytoplasm containing either increased profiles of rough endoplasmic reticulum (RER) or one or more widely dilated cisternae of RER, which displaced other cellular organelles. 2-MBI appears to act comparably to other thioureylene compounds that have been shown to produce low serum concentrations of triiodothyronine and thyroxine, which results in thyrotroph hypertrophy and hyperplasia, resultant thyroid hyperplasia, and subsequent goiter.
INTRODUCTION
2-Mercaptobenzimidazole (2-MBI) is frequently used as an accelerator and/or antioxidant in rubber processing (22) . 2-MBI is a thioureylene compound and is structurally similar to ethylenethiourea, a known thyroid carcinogen (2) . Inhalational exposure of industrial workers to 2-MBI during rubber processing raises concerns regarding the potential thyroid injury and carcinogenicity of 2-MBI. Thioureylene compounds inhibit thyroid function by abrogating the synthesis of triiodothyronine (T3) and thyroxine (T4) through a variety of subcellular mechanisms (6-9, 21, 25, 28, 30, 31) . Based on its structural similarity to other thioureylene compounds, it was hypothesized that 2-MBI would inhibit thyroid function and possibly induce thyroid and pituitary lesions. Janssen et al previously reported that 2-MBI is a metabolite of the immunomodulator 3-(p-chlorophenyl)-2,3-dihydro-3-hydroxythiazolo [3,2a] benzimidazole-2-acetic acid and that both compounds increased thyroid weights and decreased serum concentrations ofT~ in rats (19) . In review of a previous unpublished subchronic study, sponsored by the National Toxicology Program, National Institute of Environmental Health Sciences (Research Triangle Park, NC), rats in several dose groups exposed to 2-MBI had marked goiter and enlarged granular or vacuolated pituitary cells that resembled &dquo;thyroidectomy cells&dquo; (3, 24, 27) . The goals of this investigation were to characterize the morphologic changes in the pituitary glands of rats exposed to 2-MBI and to determine if the enlarged cells within the pituitary were thyrotrophs similar to thyroidectomy cells.
MATERIALS AND METHODS
Seven-wk-old male Fischer-344 rats (Taconic Farms Inc., Germantown, NY) that weighed 129-207 g were exposed to 2-MBI via inhalation for 13 wk, 6 hr/day, 5 days/wk, at the following concentrations : 50.0, 12.5, 3.13, and 0.0 mg/m3. Aerosols of 2-MBI were generated and monitored as described previously (12) . Briefly, aerosols of 2-MBI were generated through a wet dispersion technique, using a pneumatic spray nozzle. Mass concentrations of 2-MBI in aerosols were monitored continuously with RAM-S real-time aerosol monitors (MIE, Inc., Bedford, MA) and on an hourly basis utilizing gravimetric filter samples collected from measured volumes of the generated aerosols. Particle size of aerosol in chamber atmosphere was determined to range from 1.7 to 2.7 4m during the study period, using a quartz crystal microbalance piezoelectric cascade impactor. There were 19 rats per treatment group; 3 rats per treatment group were sacrificed at 2, 4, or 8 wk postexposure. The remaining 10 rats were sacrificed after 13 wk of exposure. All rats were housed in stainless steel cages, fed NIH 07 diet (Ziegler Bros., Gardners, PA), and given water ad libitum; rats were maintained on a 12-hr light-dark cycle and at an ambient temperature of 24°C. All animals were maintained in accordance with Good Laboratory Practice Regulations.
Pituitary and Thyroid Glands. Pituitary and thyroid glands were collected at the end of the designated exposure periods, except for 5 animals of the 50-mg/m3 group that died or were sacrificed when moribund. The pituitary and thyroid glands were bisected and 1 portion of each organ was placed in Bouin's fixative for 12 hr, washed in 70% ethanol, routinely processed, and embedded in paraffin. The other half of each gland was immersed in Mc-Dowell-Trump's fixative for transmission electron microscopy. Sections of Bouin's-fixed pituitary and thyroid glands were mounted on gelatin adhesivecoated slides and stained with hematoxylin and eosin (H&E).
Pituitary glands from 1 rat in each of the 0.0-, 3.13-, and 50.0-mg/m3 2-MBI treatment groups and 2 rats treated with 12.5 mg/m3 were not examined, due to either insufficient tissue or marked autolysis (Table II) .
Histologic lesions in the pituitaries were graded subjectively on a scale of 0-4: 0 representing no significant microscopic lesions; 1 representing minimal changes characterized by occasional foci of en-larged cells (5) (6) (7) (8) (9) (10) , either with stippled cytoplasm or with eosinophilic globules in single or multiple vacuoles; 2 representing mild changes characterized by numerous foci to coalescing sheets of cells described in grade 1; 3 representing moderate changes characterized by sheets of cells described in grade 1; 4 representing marked changes similar to 3 but with sheets of cells obliterating the anterior pituitary. Concurrent thyroid hypertrophy and hyperplasia were graded on a 0-4 scale: 0 representing no significant lesions; 1 representing minimal changes characterized by a focal area of follicles lined by tall columnar cells with pale colloid and smaller follicular lumens; 2 representing a locally extensive area or multifocal areas of follicles as described in grade 1; 3 representing multifocal to coalescing area of follicles described in grade 1, plus follicles lined by multiple layers of epithelial cells that partially occluded the follicular lumens; 4 representing a diffuse area of follicles as in grade 3, usually devoid of colloid and lumens occluded by hypertrophic follicular epithelium.
Pituitary glands from 5 rats treated with 50.0 mg/ m3 of 2-MBI were processed for electron microscopy. Two of the rats were sacrificed 13 wk postexposure, and 1 each was sacrificed at 2, 4, and 8 wk postexposure. Pituitary glands were postfixed in 1 % osmium tetroxide (pH 7.2) in 0.1 M phosphate buffer, dehydrated in a graded series of ethanol, passed through 100% acetone, and embedded in Spurr's resin. Ultrathin sections were stained with uranyl acetate and lead citrate and examined with a Philips 410 transmission electron microscope.
Immunohistochemistry and Histochemistry of Pituitary Glands. Paraffin-embedded pituitary glands from 6 rats exposed to 3.13 mg/m3 and 6 rats exposed to 12.5 mg/m3 of 2-MBI were selected for immunohistochemical analysis of the ¡3-chain of thyroid-stimulating hormone (TSH) (5, 14, 26) . The groups of 6 animals were composed of 3 rats (randomly selected) from the 13-wk period and 1 from each of the 2-, 4-, and 8-wk periods. In addition, pituitary glands from 5 in the 50.0-mg/m3 group exposed to 2-MBI for 13 wk, and 4 rats treated similarly, but which were sacrificed while moribund or found dead before 13 wk of treatment, were evaluated immunohistochemically. Twelve control rats were also studied. Pituitary sections were stained using a commercial peroxidase-antiperoxidase Representative sections of pituitary from 6 rats per treatment group from the 13-wk exposure group were chosen for histochemistry (24 sections in total). Pituitary sections were stained with periodic acid-Schiff hematoxylin-light green orange G (PHLOG) and combined aldehyde fuchsin-acetic alum hematoxylin trichrome (aldehyde fuchsin) (4). With these stains basophils (gonadotrophs, corticotrophs, and thyrotrophs) were periodic acid-Schiff (PAS) positive, acidophils (somatotrophs) were orange G positive (orange), and thyrotrophs were stained specifically with aldehyde fuchsin (magenta).
Thyroparathyroidectomy. Two thyroparathyroidectomy studies were performed. In the first study, 8 male F-344 retired breeder rats (Charles River, Raleigh, NC) were used. The range of body weight of these rats was 340-380 g. Rats were housed in suspended solid bottom polycarbonate units on ground corncob bedding. Purina rodent chow (Purina Mills, Inc., St. Louis, MO) and water were supplied ad libitum. Animals were maintained at a mean ambient temperature of 22°C and a 12-hr light-dark cycle. The rats were anesthetized via inhalation using methoxyflurane (Methane, Pittman Moore Inc., Washington Crossing, NJ) and were thyroparathyroidectomized surgically. Rats were sacrificed via C02 inhalation at the following times after surgery: 1 wk (n = 2), 2 wk (n = 1), 3 wk (n = 2), 4 wk (n = 1), and 8 wk (n = 2). For the second study, 12 7 -wk-old F-344 male rats, weighing 120-140 g, were thyroparathyroidectomized prior to arrival in our laboratory (Taconic Farms, Germantown, NY) and were housed iden-tically to the other thyroparathyroidectomized rats.
The rats were fed NIH 07 diet (Tek Lad Diets, Madison, WI) and were given water that contained a 1 % solution of calcium carbonate ad libitum. Three rats were sacrificed by CO2 inhalation at 1, 4, 8, and 13 wk after thyroparathyroidectomy.
Pituitary glands from both groups of thyroparathyroidectomized rats were bisected, fixed, and processed as described above. Pituitary glands were stained immunohistochemically for the 0-chain of TSH and histochemically with aldehyde fuchsin as described previously.
RESULTS

Thyroid Glands
Thyroid glands from control rats (0.0 mg/m3) and 14 of 19 rats treated with 3.13 mg/m3 of 2-MBI had no significant light microscopic lesions and had scores of 0 on a subjective scale (Table I ). Thyroid glands from these rats had follicles of different sizes with open lumens containing eosinophilic colloid. Thin fibrous septa separated follicles forming microlobules in a few of the glands. Three rats treated with 3.13 Mg/M3 of 2-MBI for 2 wk had mild to moderate thyroid hypertrophy/hyperplasia with an average subjective score of 2.3 (Table I) . Follicles in these glands contained tall columnar cells. Follicular lumens were uniform and had decreased volumes of colloid ( Fig. 1 ). Moderate to marked thyroid hypertrophy/hyperplasia ( Fig. 2 ) was present in 19 of 19 and 14 of 14 rats treated with 12.5 and 50.0 mg/m3 of 2-MBI, respectively (Table I) . Hyperplastic glands were composed of follicles lined by [2] [3] [4] layers of epithelial cells. These cells were slightly basophilic and had a higher nuclear/cytoplasmic ratio than controls. Follicular lumens were partially to completely occluded due to the hypertrophy and hyperplasia and lumens were either empty or only had scant amounts of pale colloid. A few follicles contained papillary projections of thyroid epithelium. Hypertrophic and hyperplastic follicles were located primarily in the center of the gland, while follicles around the periphery of the gland were similar to follicles in controls, thus giving the lesion a centripetal pattern. Thyroid glands from 12 of 14 rats treated with 50.0 mg/m3 of 2-MBI also had interstitial proliferation characterized by increased numbers of fibroblasts with a mild to moderate increase in collagen deposition (Fig. 3) . The proliferative response was marked in 2 of these rats, while it was mild to moderate in the remaining 10 animals.
Pituitary Glands
No histologic lesions were present in the pituitary glands of control rats and 12 of 18 rats treated with 3.13 mg/m3 of 2-MBI (Table II) . Six rats in the 3.13- mg/m3 treatment group had a small number of hypertrophic cells with markedly expanded cytoplasm, 3-5 times the size of adjacent cells. The cells were round to oval with amphophilic to eosinophilic stippled cytoplasm (Fig. 4 ). Cells of an identical description were present in the anterior pituitary glands in 13 of 19 rats treated with 12.5 mg/m3 of 2-MBI. The hypertrophic cells were more numerous than in the 3.13-mg/m3 group and were disseminated throughout the anterior pituitary, often in aggregates of 3-5 cells. Starting in the 3.13-mg/m3 dose group, pituitary glands had a few cells with prominent eosinophilic cytoplasmic globules (Fig. 5a ), ranging from 2 to 10 gm in diameter, packed in 1 or more large vacuoles, which displaced nuclei to the periphery (Fig. 5b ). These cells had hyperchromatic or pyknotic nuclei.
Pituitaries from 5 of 6 rats treated with 50.0 mg/ rn3 of 2-MBI and sacrificed after 2and 4-wk exposure periods had several enlarged cells but only rare to occasional cells with cytoplasmic globules. Eight of the 12 rats exposed to 2-MBI at the 50.0mg/m3 concentration for 8 wk and longer had numerous enlarged cells and cells with cytoplasmic globules. Overall, pituitary glands from 13 of the 18 rats evaluated that were treated with 50.0 Mg/M3 of 2-MBI had moderate to marked cellular hypertrophy/hyperplasia characterized by numerous enlarged cells and/or variable numbers of cells with cytologic alterations arranged in islands or sheets.
Immunohistochemistry and Histochemistry of Pituitary Glands
Cells staining as thyrotrophs in all controls and rats treated with 3.13 mg/m3 of 2-MBI were small, -50.0 rnglm3 2-MBI. 11 angular, widely scattered throughout the anterior pituitary gland and rarely in foci of 2-4 cells (Fig.  6 ). The number of cells staining as thyrotrophs was increased in rats treated with 12.5 mg/m3 of 2-MBI compared to controls. These cells were in foci of greater than 5 cells disseminated throughout the anterior pituitary. Rats treated with 50.0 mg/m3 of 2-MBI had many more thyrotrophs than any other dose group (Fig. 7a ). Most cells with cytologic alterations, as well as hypertrophic cells, contained immunohistochemically detectable TSH 0-chain (Fig. 7b ). However, approximately 10-15% of cells with cytologic alterations in the anterior pituitary of rats treated with 50 mg/m3 2-MBI did not stain with this antibody.
Hypertrophic cells in the anterior pituitary glands of rats treated with 2-MBI stained with the PAS portion of the PHLOG stain, while cells with cytoplasmic globules did not stain. Neither cell type stained with aldehyde fuchsin.
Ultrastructure of Pituitary Glands
Thyrotrophs were distinguished from other anterior pituitary cells by their small size, angular shape, and cytoplasmic granules that were 200 nm in diameter and located adjacent to the plasma membrane (13) . Pituitary glands of control rats and those treated with 3.13 mg/m3 of 2-MBI had no abnormal thyrotrophs. Rats treated with 12.5 and 50.0 mg/ m3 for each time period had variable numbers of hypertrophic, round to oval cells with numerous profiles of rough endoplasmic reticulum (RER) and abundant electron-dense 200-nm diameter granules (Fig. 8 ). Cells with cytoplasmic globules were characterized ultrastructurally by marked dilation of one to several profiles of RER that displaced cell nuclei and other organelles to the periphery (Fig. 9 ). These profiles enclosed electron-dense floccular material that often contained few variably sized round electron-dense granules (intracistemal granules) ( Fig. 10 ). Cells with cytoplasmic globules contained either few or no secretory granules and occasionally had hyperchromatic or pyknotic nuclei. Many of the cells with dilated profiles of RER contained numerous primary lysosomes and/or residual bodies often adjacent to the plasma membrane. Gonadotrophs, identified by their secretory granules, had mildly dilated RER and were infrequently observed in pituitary sections. Cells with degenerative features, such as pyknotic nuclei, condensed dark-staining cytoplasm, and vacuolated mitochondria, were rare large clear vacuoles, which displace nuclei to the periphery : 50.0 mg/m3 2-MBI. 11 wk postexposure. H&E. Bar but were present in pituitary glands from rats in all groups.
Thyroparathyroidectomy
Results from the 2 thyroparathyroidectomy studies were similar to those observed in the 2-MBIexposed rats. The anterior pituitary glands from all thyroparathyroidectomized rats contained varying numbers of cells with basophilic cytoplasm (basophils) with expanded granular cytoplasm and/or cells with a large cytoplasmic vacuole that compressed the nucleus to the periphery (thyroidectomy cells). Thyroidectomy cells were evident in the anterior pituitary of rats sacrificed as early as 1 wk after thyroparathyroidectomy. The cytoplasm of thyroidectomy cells was not stained by aldehyde fuchsin but contained TSH as detected by immunohistochemistry, as did hypertrophic cells and cells with cytoplasmic globules from 2-MBI-treated rats. There was an increase in the number and amount of vacuoles in basophils from rats that had undergone thyroparathyroidectomy compared to controls. Occasionally, within or adjacent to the cytoplasmic vacuoles were several eosinophilic globules similar to those within cells in the pituitary glands of rats treated with 2mMBI. Pituitary glands from thyroparathyroidectomized rats were not stained with the PHLOG.
Ultrastructurally, enlarged thyrotrophs had many more profiles of RER than thyrotrophs from the controls. Most thyrotrophs from the pituitary glands of rats sacrificed 4, 8, and 13 wk after thyroparathyroidectomy contained dilated profiles of RER, which displaced organelles. They had intracistemal granules within the RER identical to those within pituitary cells in rats treated with 2-MBI. Like cells with cytoplasmic globules in the anterior pituitary of the 2-MBI-treated rats, these cells had few or no secretory granules.
DISCUSSION
Inhalation exposure of rats to 2-MBI resulted in hypertrophy and hyperplasia of pituitary thyrotrophs and thyroid follicular epithelium. These lesions are consistent with those observed subsequent to chemical or physical thyroidectomy ( 1, 3, 10, 11, 15, 17, 27, 29) . It has previously been reported that the serum concentrations of T3 and T4 in rats exposed to 12.5 or 50.0 Mg/M3 of 2-MBI were significantly decreased (12) . Janssen et al also reported that 2-MBI was the metabolite of the immunomodulator 3-(p-chlorophenyl)-2,3-dihydro-3-hydroxythiazolo [3,2a] benzimidazole-2-acetic acid, which caused decreased plasma T4 levels and enlarged thyroid glands (19) . These findings suggest that 2-MBI Thioureylene compounds are known to inhibit thyroid function (28, 30) . In fact, compounds such as propylthiouracil, methimazole, and carbimazole are used clinically to treat hyperthyroidism (6, 21 ) . These compounds inhibit thyroid function by: (a) preventing coupling of iodotyrosines (monoiodotyrosine and diiodotyrosine) that combine to form iodotyrosines T3 and T4 (6-8); (b) decreasing the iodination of thyroglobulin by diverting oxidized iodide away from tyrosine residues (8, 9, 25, 29, 30) ; and (c) preventing conversion of T4 to T3, the active thyroid hormone (6, . The first 2 mechanisms are normally catalyzed by thyroid peroxidase, an intracellular thyroid enzyme, while the third is catalyzed by 5'-deiodinase, an enzyme that is located mainly within the liver, kidney, heart, thyroid, and pituitary (16, 18, 20) .
Rats treated with 12.5 and 50 mg/m3 2-MBI in our study had decreased serum T3 and T4 levels (12) . We speculate that 2-MBI inhibits production of serum T3 and T4, causing thyrotrophs to increase the synthesis and secretion of TSH in a fashion similar to that seen with chemical or physical thyroidectomy (1, 10, 15, 2~) . In our study, thyrotrophs with cytologic alterations demonstrate the previously described (3) unique morphologic and staining characteristics of thyrotrophs with experimentally induced hypertrophy, which vary based on length of time following thyroidectomy. One week after thyroidectomy, thyrotrophs enlarge and develop small cytoplasmic vesicles that eventually coalesce to form one or more large vacuoles or pale homogeneous areas (3) . Data generated from our thyroparathyroidectomy studies were consistent with these previous findings, since identical thyroidectomy cells were observed in rats sacrificed as early as 1 wk after thyroparathyroidectomy. Thyroidectomy cells usually do not stain with PAS and aldehyde fuchsin like normal thyrotrophs, but TSH can be detected by immunohistochemistry, as was observed in our study.
Thyroid hypertrophy and hyperplasia are due to prolonged stimulation by TSH, since TSH causes hypertrophy and hyperplasia of thyroid follicular epithelium (18) . Interstitial proliferation within thyroid glands of treated rats is a unique lesion, the exact cause of which is unknown. In our study, this lesion was only present in thyroid glands from rats in the 50.0-mg/m3 group and may be due to exposure to high levels of 2-MBI. This compound has been found to be incorporated and metabolized by desulfuration within the thyroid glands of rats (19) ; therefore, accumulation of 2-MBI or its metabolite may be the cause of this lesion. Chronic toxicity studies on 2-MBI may help elucidate the pathogenesis of this lesion.
Hypertrophic thyrotrophs from the 2-MBI-treated rats closely resembled thyrotrophs from thyroparathyroidectomized rats, as well as those previously described in rats and mice rendered hypothyroid by various means (3, 11, 15, 27) . Interestingly, not all hypertrophic thyrotrophs from our study or in previous studies stained immunohistochemically for the 0-chain of TSH. This lack of staining may be attributed to one of several explanations : rapid secretion of TSH, altered release of newly synthesized secretory granules, transdinerentiation of somatotrophs to thyrotrophs, insufficient concentration of TSH within thyrotrophs to be detected by the methods used, or the presence of immunoreactive components of the j8-chain of TSH that the antibodies used did not recognize. The presence of heterogeneous molecules of the 0-chain of TSH subsequent to thyroidectomy has been reported (23).
Ultrastructural results indicated that the cells with cytologic alterations seen by light microscopy were hypertrophic cells that contained large dilated profiles of RER (10, 13) . Those cells with multiple profiles of RER accounted for the light microscopic cells with cytoplasmic globules, and the cells with the large single profiles correlated with the cytoplasmic alteration characteristic of thyroidectomy cells. The contents of the dilated sacs of RER were occasionally relatively electron lucent, which may help explain the negative immunohistochemical results in some of the large thyroidectomy cells. These cells probably contained insufficient TSH in secretory granules and in the RER to be detected with the techniques used in this study. Ultrastructural immunohistochemistry would verify or refute this possibility.
A recent study indicates that somatotrophs from F-344 rats treated with propylthiouracil, a compound related to 2-MBI, may undergo transdifferentiation and develop histologic and ultrastructural characteristics similar to those of thyroidectomy cells (17) . During the first few days of their transdifferentiation, these cells stained weakly for the 0-chain of TSH. It is possible that some of the hypertrophic cells seen in this study represent transdifferentiated somatotrophs, which have insufhcient TSH to be recognized by light microscopic immunohistochemistry.
In summary, 2-MBI induces chemical hypothyroidism and compensatory changes in the pituitary, based on immunohistochemical, histochemical, serologic, and ultrastructural evaluations. The results of the present study provide further evidence, based on the hypertrophic changes of thyrotrophs and thyroid hypertrophy, that 2-MBI has antithyroid activity and that cells in the pituitary with cytoplasmic globules are hypertrophic thyrotrophs.
